$35.50
▼ -1.5% Today
as of Jul 22, 16:55 ET
Last 30 days
Recent Press Releases & News
Gentherm Acquires Innovative Medical Equipment, LLC, Strengthening Medical Product Portfolio and Customer Channels
Gentherm Wins FDA Clearance for ThermAffyx Safety System
Gentherm Medical Receives FDA Clearance for ThermAffyx™ Patient Safety System
Overview
52-week range
$27
$39
68% of range
Avg surprise (last 2)
-1.1%
Avg reaction (last 2)
+1.2%
50% positive
Latest IV / EM
60%
EM ±13.7% · $35 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Mar 31, 2026 | Mar 2026 | $0.14 | — | — | — | — | financials |
| Tue Sep 30, 2025 | Sep 2025 | $0.49 | — | — | — | — | financials |
| Thu Jul 24, 2025 | Jun/2025 | $0.54 | $0.59 | -8.5% | — | +2.7% | earnings |
| Thu Apr 24, 2025 | Mar/2025 | $0.51 | $0.48 | +6.2% | — | -0.3% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $0.51 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $0.60 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $0.47 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $0.48 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.05 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Thu Jul 23, 2026 | Jun/2026 | BMO | $0.59 | $0.54 | +9.3% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of revenue | $296M | — | $292M | $285M | $267M | — | $277M | $279M |
| Gross profit | $97M | — | $95M | $90M | $86M | — | $95M | $97M |
| Operating income | $11M | — | $24M | $24M | $17M | — | $32M | $33M |
| Net income | — | — | — | — | — | — | — | — |
| EPS (diluted) | $0.14 | — | $0.49 | $0.02 | — | — | $0.51 | $0.60 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $177M | $161M | $154M | $128M | $163M | $134M | $151M | $123M |
| Inventory | $257M | $253M | $253M | $248M | $236M | $227M | $234M | $214M |
| Total current assets | $826M | $777M | $786M | $759M | $764M | $684M | $737M | $690M |
| Total assets | $1.43B | $1.40B | $1.38B | $1.36B | $1.34B | $1.25B | $1.30B | $1.24B |
| Long-term debt | $219M | $189M | $189M | $209M | $262M | $220M | $222M | $222M |
| Total liabilities | $714M | $676M | $663M | $662M | $698M | $631M | $637M | $600M |
| Total equity | $716M | $720M | $718M | $700M | $647M | $617M | $661M | $640M |